JPRN-jRCT1051230149招募中4 期
Survey of dotinurad use in hyperuricemic patients with impaired renal function-A retrospective observational study
Shimazu keiji0 个研究点目标入组 500 人开始时间: 2023年12月21日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 500
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- >= 20age old 至 ot applicable(—)
- 性别
- All
入选标准
- •1)Of the patients who were prescribed dotinurad at Osaka Saiseikai Nakatsu Hospital (hereafter referred to as this hospital) during the study period, those patients could be classified into eGFR categories G1 to G5 at the start of dotinurad administration.
- •2)Patients (of any gender) 20 years of age or older at the start of dotinurad treatment.
排除标准
- •1)Patients who visited our clinic after being started on dotinurad at another medical institution (patients who were already taking dotinurad at the time of their first visit to our clinic).
- •2)Patients who indicated their intention not to participate by opting out.
研究者
相似试验
招募中
Unknown
Clinical Study on Dotinurad for HyperuricemiaJPRN-UMIN000054142Sekino Hospital40
已完成
4 期
Effect of dotinurad in hyperuricemia with hypertension (DIANA)hyperuricemia complicated by hypertensionJPRN-jRCTs021210013ode Koichi54
已完成
不适用
Use of Febuxostat in Hyperuricemia Among Hemodialysis PatientsHemodialysis ComplicationHyperuricemiaNCT03149939Benha University19
尚未招募
2 期
Effect of Unani medicine in joint paiCTRI/2022/04/042162ational Institute of Unani Medicine
招募中
Unknown
Clinical Study on Additional Treatment of Hyperuricemia with DotinuradJPRN-UMIN000054141Sekino Hospital20
